[SÁCH][B] Development and Evaluation of a Nurse Practitioner-Directed Bone Health Screening for Prostate Cancer Patients in an Oncology Practice

A Adewale - 2023 - search.proquest.com
Bone health impairment is a recurring detrimental outcome of prostate cancer cells' high
bone tropism. The impairment is further exacerbated by administering androgen deprivation …

Comparative pharmacokinetic study of bicalutamide administration alone and in combination with vitamin D in rats

W Shi, H Di, B Pang, H **, H Liu, B Qiu… - Acta …, 2021 - akjournals.com
Bicalutamide (BCL) has been approved for treatment of advanced prostate cancer (Pca),
and vitamin D is inevitably used in combination with BCL in Pca patients for skeletal or anti …

Bone Mineral Density in Patients with Metastatic Prostate Cancer with or without Androgen Deprivation Therapy

I Hyder, A Hafeez, M Waqas - Medical Forum Monthly, 2022 - medicalforummonthly.com
Objective: To evaluate the bone mineral density in patients of malignant prostate cancer with
and without use of androgen deprivation therapy. Study Design: Case control study Place …